Abstract
Alemtuzumab for multiple sclerosis.
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1002/14651858.cd011203.pub2
Copy DOIPublication Date: Apr 15, 2016 | |
Citations: 25 |
Alemtuzumab for multiple sclerosis.
Join us for a 30 min session where you can share your feedback and ask us any queries you have